These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31545478)

  • 1. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
    Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
    Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
    PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
    Zeng W; Chang H; Ma M; Li Y
    Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer.
    Wang GZ; Cheng X; Li XC; Liu YQ; Wang XQ; Shi X; Wang ZY; Guo YQ; Wen ZS; Huang YC; Zhou GB
    Cancer Lett; 2015 Jul; 363(1):60-70. PubMed ID: 25864589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CCL20 promotes the paclitaxel resistance of CD44
    Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
    Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
    Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
    PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
    Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
    Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
    Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
    Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.
    Zhang J; Zhu D; Lv Q; Yi Y; Li F; Zhang W
    Tumour Biol; 2015 Dec; 36(12):9763-7. PubMed ID: 26156805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine (C-C) motif ligand 20 is regulated by PGF(2α)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation.
    Wallace AE; Catalano RD; Anderson RA; Jabbour HN
    Mol Cell Endocrinol; 2011 Jan; 331(1):129-35. PubMed ID: 20816914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer.
    Ouyang J; Hu S; Zhu Q; Li C; Kang T; Xie W; Wang Y; Li Y; Lu Y; Qi J; Xia M; Chen J; Yang Y; Sun Y; Gao T; Ye L; Liang Q; Pan Y; Zhu C
    Cell Death Dis; 2024 Jun; 15(6):437. PubMed ID: 38902257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis.
    Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z
    Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL20/CCR6 expression profile in pancreatic cancer.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Grimm H; Vicinus B; Justinger C; Graeber S; Schilling MK
    J Transl Med; 2010 May; 8():45. PubMed ID: 20459729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
    Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
    Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.